Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis
- Study Title
- Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis
- Teva Identifier
- LA-LAQ-202
- ClinicalTrials.gov Identifier
- NCT01085084
- Study Status
- Completed
- Trial Condition(s)
- Lupus Arthritis
- Interventions
- Drug: Laquinimod | Other: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years to 75 Years
- Trial Duration
- 07/01/2010 - 10/01/2012
- Phase
- Phase 2
